Literature DB >> 7758108

Unique response pathways are established by allosteric interactions among nuclear hormone receptors.

B M Forman1, K Umesono, J Chen, R M Evans.   

Abstract

Heterodimerization is a common paradigm among eukaryotic transcription factors. The 9-cis retinoic acid receptor (RXR) serves as a common heterodimerization partner for several nuclear receptors, including the thyroid hormone receptor (T3R) and retinoic acid receptor (RAR). This raises the question as to whether these complexes possess dual hormonal responsiveness. We devised a strategy to examine the transcriptional properties of each receptor individually or when tethered to a heterodimeric partner. We find that the intrinsic binding properties of RXR are masked in T3R-RXR and RAR-RXR heterodimers. In contrast, RXR is active as a non-DNA-binding cofactor with the NGFI-B/Nurr1 orphan receptors. Heterodimerization of RXR with constitutively active NGFI-B/Nurr1 creates a novel hormone-dependent complex. These findings suggest that allosteric interactions among heterodimers create complexes with unique properties. We suggest that allostery is a critical feature underlying the generation of diversity in hormone response networks.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7758108     DOI: 10.1016/0092-8674(95)90075-6

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  178 in total

1.  Structure of the RXR-RAR DNA-binding complex on the retinoic acid response element DR1.

Authors:  F Rastinejad; T Wagner; Q Zhao; S Khorasanizadeh
Journal:  EMBO J       Date:  2000-03-01       Impact factor: 11.598

2.  AHR38, a homolog of NGFI-B, inhibits formation of the functional ecdysteroid receptor in the mosquito Aedes aegypti.

Authors:  J Zhu; K Miura; L Chen; A S Raikhel
Journal:  EMBO J       Date:  2000-01-17       Impact factor: 11.598

3.  Mutual activation of Ets-1 and AML1 DNA binding by direct interaction of their autoinhibitory domains.

Authors:  W Y Kim; M Sieweke; E Ogawa; H J Wee; U Englmeier; T Graf; Y Ito
Journal:  EMBO J       Date:  1999-03-15       Impact factor: 11.598

4.  Dominant activity of activation function 1 (AF-1) and differential stoichiometric requirements for AF-1 and -2 in the estrogen receptor alpha-beta heterodimeric complex.

Authors:  G B Tremblay; A Tremblay; F Labrie; V Giguère
Journal:  Mol Cell Biol       Date:  1999-03       Impact factor: 4.272

5.  Ligand-dependent degradation of retinoid X receptors does not require transcriptional activity or coactivator interactions.

Authors:  D L Osburn; G Shao; H M Seidel; I G Schulman
Journal:  Mol Cell Biol       Date:  2001-08       Impact factor: 4.272

6.  Loss of p19(ARF) eliminates the requirement for the pRB-binding motif in simian virus 40 large T antigen-mediated transformation.

Authors:  H H Chao; A M Buchmann; J A DeCaprio
Journal:  Mol Cell Biol       Date:  2000-10       Impact factor: 4.272

7.  Modulation of retinoic acid sensitivity in lung cancer cells through dynamic balance of orphan receptors nur77 and COUP-TF and their heterodimerization.

Authors:  Q Wu; Y Li; R Liu; A Agadir; M O Lee; Y Liu; X Zhang
Journal:  EMBO J       Date:  1997-04-01       Impact factor: 11.598

Review 8.  Alcohol and aldehyde dehydrogenases: retinoid metabolic effects in mouse knockout models.

Authors:  Sandeep Kumar; Lisa L Sandell; Paul A Trainor; Frank Koentgen; Gregg Duester
Journal:  Biochim Biophys Acta       Date:  2011-04-15

9.  RXR activators molecular signalling: involvement of a PPAR alpha-dependent pathway in the liver and kidney, evidence for an alternative pathway in the heart.

Authors:  Laïla Ouamrane; Gilberte Larrieu; Béatrice Gauthier; Thierry Pineau
Journal:  Br J Pharmacol       Date:  2003-03       Impact factor: 8.739

10.  Nurr1-RXR heterodimers mediate RXR ligand-induced signaling in neuronal cells.

Authors:  Asa Wallen-Mackenzie; Alexander Mata de Urquiza; Susanna Petersson; Francisco J Rodriguez; Stina Friling; Joseph Wagner; Peter Ordentlich; Johan Lengqvist; Richard A Heyman; Ernest Arenas; Thomas Perlmann
Journal:  Genes Dev       Date:  2003-12-17       Impact factor: 11.361

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.